logo

CDTX(Delisted)

Cidara Therapeutics·NASDAQ
--
--(--)
Latest data update time: Updated on 2026-01-01
6.16 / 10Overall Score
OutperformInvestment Rating
FundamentalSentimentTechnical
Trend Analysis of CDTX
  • Based on a composite score of 6.16/10, we rate CDTX as a Outperform. Our analysis breaks down into 5.47/10 for Fundamentals, 6.21/10 for Technicals, and 6.47/10 for Sentiment, indicating the stock is likely to See further upside.
Is CDTX undervalued or overvalued?
Technical Analysis of CDTX?
Is money flowing into or out of CDTX?